Related references
Note: Only part of the references are listed.Physiopathology of intestinal barrier and the role of zonulin
Gian Paolo Caviglia et al.
MINERVA BIOTECNOLOGICA (2019)
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Israr Khan et al.
PATHOGENS (2019)
The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response
Sydney Lavoie et al.
ELIFE (2019)
Pathogenesis of Inflammatory Bowel Disease: Basic Science in the Light of Real-World Epidemiology
Davide Giuseppe Ribaldone et al.
GASTROINTESTINAL DISORDERS (2019)
Inflammation in gastrointestinal disorders: prevalent socioeconomic factors
Davide Giuseppe Ribaldone et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2019)
Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy
Yizhong Wang et al.
JOURNAL OF CROHNS & COLITIS (2018)
Inflammation: a highly conserved, Janus-like phenomenon-a gastroenterologist' perspective
Davide Giuseppe Ribaldone et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients
Matthew K. Doherty et al.
MBIO (2018)
Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease
Ahmed Moustafa et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
The Human Gut Microbiome - A Potential Controller of Wellness and Disease
Zhi Y. Kho et al.
FRONTIERS IN MICROBIOLOGY (2018)
Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
Hengaineh Chloe Mirsepasi-Lauridsen et al.
FRONTIERS IN MEDICINE (2018)
From Culturomics to Clinical Microbiology and Forward
Gregory Dubourg et al.
EMERGING INFECTIOUS DISEASES (2018)
The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review
Rosario Lucas Lopez et al.
APMIS (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Host-microbial Cross-talk in Inflammatory Bowel Disease
Hiroko Nagao-Kitamoto et al.
IMMUNE NETWORK (2017)
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease (vol 18, pg 489, 2015)
James D. Lewis et al.
CELL HOST & MICROBE (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan et al.
CELL HOST & MICROBE (2017)
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2016)
Gut Bifidobacteria Populations in Human Health and Aging
Silvia Arboleya et al.
FRONTIERS IN MICROBIOLOGY (2016)
A Multi-Omics Approach to Evaluate the Quality of Milk Whey Used in Ricotta Cheese Production
Eleonora Sattin et al.
FRONTIERS IN MICROBIOLOGY (2016)
Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease
David Busquets et al.
JOURNAL OF CROHNS & COLITIS (2015)
Anti-TNF therapy: past, present and future
Claudia Monaco et al.
INTERNATIONAL IMMUNOLOGY (2015)
Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis
David Rios-Covian et al.
FEMS MICROBIOLOGY LETTERS (2015)
Intestinal microbiota: A source of novel biomarkers in inflammatory bowel diseases?
David Berry et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2013)
Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease
Eliseo Papa et al.
PLOS ONE (2012)
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
Marie Joossens et al.
GUT (2011)
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
Michael B. Sprakes et al.
JOURNAL OF CROHNS & COLITIS (2011)
Next-Generation Sequencing: From Basic Research to Diagnostics
Karl V. Voelkerding et al.
CLINICAL CHEMISTRY (2009)
Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease
S Saitoh et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2002)
Share Paper
